Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies.
Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies.
复制标题
DOI:
10.1158/1055-9965.epi-09-0618
复制
发表时间:
2010-03
期刊:
影响因子:
--
通讯作者:
Kraft P
中科院分区:
文献类型:
--
作者:
Lindström S;Hunter DJ;Grönberg H;Stattin P;Wiklund F;Xu J;Chanock SJ;Hayes R;Kraft P
Genetic variation in two members of the Toll-like receptors family, TLR4 and the gene cluster TLR6-1-10, has been implicated in prostate cancer in several studies, but the associated alleles have not been consistent across reports. We performed a pooled analysis combining genotype data from three case-control studies, CAPS, HPFS and PLCO, with data from 3,101 prostate cancer cases and 2,523 controls. We performed imputation to obtain dense coverage of the genes and comparable genotype data for all cohorts. In total, 58 SNPs in TLR4 and 96 SNPs in TLR6-1-10 were genotyped or imputed and analyzed in the entire dataset. We performed cohort-specific analysis as well as meta-analysis and pooled analysis. We also evaluated whether the analyses differed by age or disease severity. We observed no overall association between genetic variation at the TLR4 and TLR6-1-10 loci and risk of prostate cancer. Common germline genetic variation in TLR4 and TLR6-1-10 does not appear to have a strong association with risk of prostate cancer.